NCT06111430Recruiting
Long-term Neurovascular Complications After Radiation Therapy in Head and Neck Cancer
The Ambidirectional Cohort Study of Neurovascular Complications After Radiation Therapy in Head and Neck Cancer Patients
Source: ClinicalTrials.gov · Last updated 22 Oct 2026
Brief summary (registry, in English)
Head and neck cancer is a group of cancers develop from the soft tissues, salivary gland, mucosa of the upper respiratory or digestive system covering the oral and nasal cavity. Radiotherapy is usually the standard treatment of Head and neck cancers. In the present study, investigators aim to study the prevalence of cervical-cranial vascular complications during the early stages in these Head and neck cancer patients receiving Radiotherapy. Investigators will also compare the results between Nasopharyngeal cancer and other Head and neck cancerpatients receiving Radiotherapy.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 800 (estimated)
- First submitted
- 17 Oct 2023
- Start date
- 11 Apr 2022
- Primary completion date
- 10 Apr 2023
- Lead sponsor
- Chang Gung Memorial Hospital
- Diseases
- Head and neck cancer
- NCT number
- NCT06111430
What you commit to
- Study type: Observational
- Planned participants: 800
- From 11 Apr 2022 to the primary completion date, 10 Apr 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Age \<20 years.
- 1.Age \<20 years.
Other
- Patients not willing to sign the informed consent.
- Population: Retrospective validation cohort
Who the study is looking for
- Age ≥20 years.
- Head and neck cancer patient .
- Had ever received radiation therapy (RT) ≦ 72 months before inclusion in the registry.
- Had ≥ 1 brain images and cervical-cranial vascular studies between the end of RT and d date of enrolment.
- Age ≥20 years.
- Head and neck cancer patient.
- Had ever received radiation therapy (RT) \> 120 months before the adoption date of IRB at the participant site.
- Had ≥ 2 brain images and cervical-cranial vascular studies between the end of RT and 6\~10 years after RT, one within 5 years after RT, the other after 5 years after RT.
Criteria the registry did not label
- Population: Prospective cohort
Age in the registry: 20 years to 100 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Chang Gung Memorial Hospital Coordinator of this site? Confirm its status | Taipei | Taiwan | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.